Brief: Cumberland Pharmaceuticals Launches RediTrex Product Line For Active Rheumatoid, Juvenile Idiopathic And Severe Psoriatic Arthritis
29/09/2021 14:33
Sept 29 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS LAUNCHES REDITREX® PRODUCT LINE
FOR
ACTIVE RHEUMATOID, JUVENILE IDIOPATHIC AND SEVERE PSORIATIC
ARTHRITIS
Source text for Eikon: ID:nPn3Y5lRXa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM